MANAGEMENT INSIGHT – Ding Dong, Your CRO’s Calling: Lessons From the World’s Largest Direct Marketer Part 4 of a 6-part series on lessons learned from other industries.
Derek G. Hennecke continues with part 4 of his 6-part series on lessons learned from other industries.
EXECUTIVE INTERVIEW – The Contract Diagnostics Organization: Revolutionizing Management for Co-Development of Companion Diagnostics
Mathew W. Moore, PhD, and Philip D. Cotter, PhD, Principals and Co-Founders of ResearchDx, discuss the concept of a CDO and how this new business model stands to impact personalized medicine and revolutionize management of the co-development of companion diagnostics.
Dr. Rod Ray, CEO and Chairman at Bend Research, discusses his company’s approach to difficult drug delivery challenges and the core technologies offered by his company.
Dr. Jean-Luc Herbeaux, the Head of the Health Care Business Line of Evonik, discusses the rationale and success of his company’s latest acquisition.
EXECUTIVE INTERVIEW – Ezose Sciences: High-Throughput Glycomics for Biomarker Discovery – Bringing Glycan Analysis Into Everyday Research
Scott Siegel, PhD, VP of Business Development at Ezose, discusses how his unique company is catalyzing progress across an emerging research front.
Derek G. Hennecke continues with part 3 of his 6-part series on lessons learned from other industries.
Contributor Cindy H. Dubin interviewed leading players in the prefilled syringe market to find out about their offerings and how they are addressing pharma’s needs for safety, ease of use, cost, and product differentiation.
ANALYTICAL TESTING – Diffusion Kinetics & Permeation Concentration of Human SC Characterization by Terahertz Scanning Reflectometry
Anis Rahman, PhD; Scott Frenchek; Brian Kilfoyle; Leena Patterkine, PhD; Aunik Rahman; and Bozena Michniak- Kohn, PhD; use terahertz reflectometry and spectrometry to investigate the permeation kinetics and concentration profile of active ingredients into the stratum corneum.
Derek G. Hennecke continues with part 2 of his 6-part series on lessons learned from other industries.
Carl Levoguer, PhD, examines how laser diffraction technology has been fashioned to powerfully support every stage of the drug development cycle.
EXCLUSIVE ONLINE CONTENT
Stevanato Group has recently launched an Artificial Intelligence platform, based on Deep Learning (DL) models, that leverages the benefits of….
Catalent to Acquire Delphi Genetics & Launch US Plasmid Manufacturing Site to Establish Global pDNA Development & Manufacturing Capabilities
Catalent and Delphi Genetics recently announced they have entered into a final and definitive agreement whereby Catalent will acquire 100% of the shares of Delphi Genetics. Catalent is also….
Halberd Collaborates With GreenBioAZ for the Development of Radio Frequency Technology to Eliminate Disease Pathogens
Halberd Corporation has engaged GreenBioAZ, Inc. to conduct laboratory testing of Halberd’s patent pending Radio Frequency (RF) extracorporeal treatment to eliminate….
Samsung Biologics recently announced another successful Investigational New Drug (IND) clearance from the FDA for its client to begin clinical trials on a cancer immunotherapy, furthering the….
Maravai LifeSciences, Inc. recently announced the United States Patent and Trademark Office has issued a new patent, United States Patent No. 10,913,768, to the company’s TriLink Biotechnologies subsidiary…..